Michael Hund — SPARQNOW

At-a-Glance

Serves as CEO of EB Research Partnership, a medical research organization dedicated to curing EB and scaling its model to rare disease.
Co-Founder of Rare Ventures.
Led EBRP to raise over $70 million, transforming the landscape from 2 to over 50 clinical trials and accelerating 3 FDA approved treatments.
Executive Producer of the award-winning Netflix documentary "Matter of Time" and "Venture into Cures."
Holds an MBA from Yale University and a CORe credential from Harvard Business School.
Recipient of the MIT Solve Innovation Award and IAOTP's Top CEO of the Year in Medical Research.

Biography

Michael Hund is an award-winning CEO with more than 20 years of experience in the innovative business models of venture philanthropy, impact investing, and medtech entrepreneurship. He is the Co-Founder of Rare Ventures and currently serves as the CEO of EB Research Partnership (EBRP), a medical research organization dedicated to curing EB and scaling its model to rare disease.